L864-2935 Screening compound: N-cyclopropyl-1-[7-oxo-6-({[(thiophen-2-yl)methyl]carbamoyl}methyl)-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl]piperidine-3-carboxamide

L864-2935 Screening compound: N-cyclopropyl-1-[7-oxo-6-({[(thiophen-2-yl)methyl]carbamoyl}methyl)-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl]piperidine-3-carboxamide
L864-2935 Screening compound: N-cyclopropyl-1-[7-oxo-6-({[(thiophen-2-yl)methyl]carbamoyl}methyl)-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L864-2935
N-cyclopropyl-1-[7-oxo-6-({[(thiophen-2-yl)methyl]carbamoyl}methyl)-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L864-2935

Molecular Formula

C21H24N6O3S2 (C21 H24 N6 O3 S2)

Compound Name

N-cyclopropyl-1-[7-oxo-6-({[(thiophen-2-yl)methyl]carbamoyl}methyl)-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-2-yl]piperidine-3-carboxamide

IUPAC name

N-cyclopropyl-1-[7-oxo-6-({[(thiophen-2-yl)methyl]carbamoyl}methyl)-6H7H-[13]thiazolo[45-d]pyrimidin-2-yl]piperidine-3-carboxamide

SMILES

O=C(CN(C=Nc1c2sc(N(CCC3)CC3C(NC3CC3)=O)n1)C2=O)NCc1cccs1

InChI

InChI=1S/C21H24N6O3S2/c28-16(22-9-15-4-2-8-31-15)11-27-12-23-18-17(20(27)30)32-21(25-18)26-7-1-3-13(10-26)19(29)24-14-5-6-14/h2,4,8,12-14H,1,3,5-7,9-11H2,(H,22,28)(H,24,29)/t13-/m0/s1

InChI Key

NONQXTIGCVFISL-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD15135673

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.690

Distribution Coefficient, logD

1.690

Water Solubility, LogSw

-2.41

Polar Surface Area

90.081

Acid Dissociation Constant (pKa)

13.13

Base Dissociation Constant (pKb)

0.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.60

L864-2935 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with L864-2935 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L864-2935?
Check Price and Availability of L864-2935, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L864-2935 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L864-2935
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L864-2935
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L864-2935 available by request